A novel, centrally acting mammalian aminosterol, ENT ‐03, induces weight loss in obese and lean rodents

Documenti analoghi

• A novel structured, volume‐based, weight‐loss and health programme combined with respiratory muscle training helps reduce weight and cardiovascular risk in people with obesity
  di: Nina Bausek, et al.
  Pubblicazione: (2024)
• Real‐world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinic
  di: Jason M. Samuels, et al.
  Pubblicazione: (2025)
• Evaluation of leptin treatment on maintenance of body weight loss in diet‐induced obese mice
  di: Danna M. Breen, et al.
  Pubblicazione: (2025)
• The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity
  di: Iskandar Idris, et al.
  Pubblicazione: (2025)
• Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study
  di: Mathieu Alissou, et al.
  Pubblicazione: (2025)